TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01151436 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03908853 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study NCT01416662 — Predictive Biomarker (PRD): CDA mRNA
Genes: CDA; CDD
Study NCT01416662 — Safety Biomarker (SAF): CDA
Genes: CDD
Study NCT00889434 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03897621 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT02876081 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02876081 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study NCT02876081 — Predictive Biomarker (PRD); Safety Biomarker (SAF): NTSR1 mRNA
Genes: NTSR1; NTRR
Study NCT02876081 — Monitoring Biomarker (MOI): Matrix metalloproteinase 1
Genes: MMP1; CLG
Study NCT02876081 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02876081 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT02876081 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02876081 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study NCT05145114 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05145114 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01409993 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01409993 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT03908710 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02949934 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT01185587 — Predictive Biomarker (PRD): SCN5A mRNA
Genes: SCN5A
Study NCT00482092 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06310863 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02593864 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT03182465 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04410757 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02705703 — Predictive Biomarker (PRD): TAPBP mRNA
Genes: TAPBP; NGS17; TAPA
Study NCT02705703 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02705703 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01338883 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01338883 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04685811 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02761538 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03217097 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT02130141 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04874467 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT03217825 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03638466 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT03618277 — Predictive Biomarker (PRD): OCA2 mRNA
Genes: OCA2; D15S12; P
Study NCT02124174 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT05480007 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT03415009 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT01562990 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03528031 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02466165 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04785729 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03558724 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04661631 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01120379 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT00546793 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00078494 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT00693264 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03273972 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT02107898 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02689778 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02641821 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00713375 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02242344 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00800540 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04796467 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02679443 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02749825 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00636571 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02814019 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01001156 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT00937196 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05001048 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02084797 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT02084797 — Predictive Biomarker (PRD): AVPR2 mRNA
Genes: AVPR2; ADHR; DIR; DIR3; V2R
Study NCT05969691 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT02721888 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01044498 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02024308 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study NCT02024308 — Predictive Biomarker (PRD): RUNX1T1 mRNA
Genes: RUNX1T1; AML1T1; CBFA2T1; CDR; ETO; MTG8; ZMYND2
Study NCT04463706 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04561453 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00619463 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT00619463 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00619463 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04795349 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT03502109 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05336006 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00085579 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00085579 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04217980 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT03585543 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT02872441 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02872441 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02061800 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02756442 — Predictive Biomarker (PRD): HPN mRNA
Genes: HPN; TMPRSS1
Study NCT03743818 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03495817 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT04546698 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03453021 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT00314106 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00314106 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02507284 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT01079286 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01079286 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03206138 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT03372603 — Predictive Biomarker (PRD): TRPV4 mRNA
Genes: TRPV4; VRL2; VROAC
Study NCT01750502 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT00470613 — Predictive Biomarker (PRD): SGTA mRNA
Genes: SGTA; SGT; SGT1
Study NCT00639093 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT02210897 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT06256276 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04521452 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02246023 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00021164 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04060836 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT00876395 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03439839 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT01702896 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03451500 — Predictive Biomarker (PRD): GPR143 mRNA
Genes: GPR143; OA1
Study NCT03451500 — Predictive Biomarker (PRD): SERPINF1 mRNA
Genes: SERPINF1; PEDF; PIG35
Study NCT03451500 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02116816 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00223574 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00234741 — Safety Biomarker (SAF): Interleukin 12
Study NCT02606305 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT00033644 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01499511 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00293748 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04281264 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04281264 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00657566 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03588468 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT01551615 — Predictive Biomarker (PRD): SLC22A2 mRNA
Genes: SLC22A2; OCT2
Study NCT00487591 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01965795 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01965795 — Safety Biomarker (SAF): BDNF
Study NCT03137368 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03137368 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02756520 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02756520 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02756520 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT02756520 — Surrogate Endpoint (SUR): Serum phosphate
Study NCT04182893 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04182893 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04182893 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04182893 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04182893 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04659187 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01155141 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02086721 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02308176 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03704688 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04419168 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03922932 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03922932 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02793934 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02072044 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT02072044 — Predictive Biomarker (PRD): FLT4 mRNA
Genes: FLT4; VEGFR3
Study NCT02695459 — Predictive Biomarker (PRD): ELK3 mRNA
Genes: ELK3; NET; SAP2
Study NCT03355027 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT03355027 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01756755 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study NCT01510756 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT00426556 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00001371 — Predictive Biomarker (PRD): PLA2G1B mRNA
Genes: PLA2G1B; PLA2; PLA2A; PPLA2
Study NCT01865773 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01932606 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04181788 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT02683304 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT00844519 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT03021915 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT04207138 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01543841 — Monitoring Biomarker (MOI): Angiopoietin-1
Genes: ANGPT1; KIAA0003
Study NCT01414296 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02371005 — Predictive Biomarker (PRD): PF4 mRNA
Genes: PF4; CXCL4; SCYB4
Study NCT02657941 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00479518 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00971828 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00581204 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00859118 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00859118 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01975077 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02511756 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04678102 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study NCT02502448 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04137536 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00627978 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT00627978 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00627978 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT00627978 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01890993 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00315497 — Predictive Biomarker (PRD): GCA mRNA
Genes: GCA; GCL
Study NCT04943406 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03602781 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04113993 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01445106 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01445106 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04393948 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04213040 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT04213040 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02133963 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02742688 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01571349 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02852083 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00171288 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03154606 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT05415657 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00998946 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03873103 — Predictive Biomarker (PRD): SH3PXD2A mRNA
Genes: SH3PXD2A; FISH; KIAA0418; SH3MD1; TKS5
Study NCT03564262 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01228045 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01228045 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01228045 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04667988 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study NCT04667988 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05882136 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT03807076 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT00574652 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00574652 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02413762 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT00308776 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT04058912 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04058912 — Predictive Biomarker (PRD): FOXO3 mRNA
Genes: FOXO3; FKHRL1; FOXO3A
Study NCT00979511 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02403271 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04115059 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04115059 — Predictive Biomarker (PRD): PLCG2 mRNA
Genes: PLCG2
Study NCT02292225 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT02140203 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03116308 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT00691379 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03942588 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04167670 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT00738088 — Predictive Biomarker (PRD): TCF7L2 mRNA
Genes: TCF7L2; TCF4
Study NCT04542564 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02761031 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01136915 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01430884 — Predictive Biomarker (PRD): SERPINA5 mRNA
Genes: SERPINA5; PCI; PLANH3; PROCI
Study NCT02038569 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02281877 — Predictive Biomarker (PRD): NCAM1 mRNA
Genes: NCAM1; NCAM
Study NCT04065620 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00709033 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00709033 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT01593579 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02337127 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03179267 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02066246 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02880059 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04071132 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04071132 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT04071132 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02334670 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01646463 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT01646463 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02756468 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT02756468 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05186155 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05186155 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01355367 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00757900 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04469283 — Predictive Biomarker (PRD): ADCY5 mRNA
Genes: ADCY5
Study NCT04412187 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT04412187 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT00534651 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04136132 — Predictive Biomarker (PRD): CHAF1A mRNA
Genes: CHAF1A; CAF; CAF1P150
Study NCT03588520 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04141553 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01013168 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00055237 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00055237 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00055237 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04355273 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00102635 — Predictive Biomarker (PRD): HPR mRNA
Genes: HPR
Study NCT03794752 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03784495 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02063269 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Cholinesterase
Genes: BCHE; CHE1
Study NCT02362451 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT02476162 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05104346 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03853928 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2